Table 1.

Patients and treatment characteristics

Patients (n = 20)
Sex
Men	35% (n = 7)
Women	65% (n = 13)
Median age (years), (range)	66 (48–76)
Primary cancer
Breast	50% (n = 10)
Prostate	25% (n = 5)
Lung	20% (n = 4)
Small bowel	5% (n = 1)
Histological types
Adenocarcinoma	55% (n = 11)
Infiltrating ductal carcinoma	35% (n = 7)
Infiltrating lobular carcinoma	5% (n = 1)
Neuro-endocrine tumor	5% (n = 1)
Vertebral lesions	22
Vertebrae treated in post-operative situation	1
Location of spinal lesions
Thoracic spine	55% (n = 12)
Lumbar spine	41% (n = 9)
Sacrum	4% (n = 1)
Treatment
Mean GTV (cm3), (range)	9.96 (0.40–42.30)
Mean CTV (cm3), (range)	32.35 (8.74–99.50)
Prescribed dose
5 × 7 Gy	100% (n = 20)